Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy with Lipiodol embolization for advanced hepatocellular carcinoma …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
A Phase II single-arm study evaluating carbon ion radiotherapy combined with atezolizumab and bevacizumab for advanced hepatocellular carcin…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma [NA]
A clinical trial is evaluating whether different infusion times of tislelizumab improve outcomes for patients with postoperative high-risk h…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of GV20-0251 in Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 clinical trial update indicates that GV20-0251 is being studied in advanced or refractory solid tumors and is currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation [Phase 3]
A Phase 3 trial evaluating nivolumab for preventing recurrence of hepatocellular carcinoma after curative liver resection or ablation; the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D) [NA]
Clinical trial RAPY90D investigates personalized Yttrium-90 dosimetry-based radioembolization with curative intent for unresectable hepatoce…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma. [Phase 1]
A Phase 1 clinical trial of TQB2223 in combination with AK105 for advanced hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Imjudo & Imfinzi PMS
AstraZeneca-sponsored trial update notes ongoing recruitment for Imjudo (tremelimumab) plus Imfinzi (durvalumab) in hepatocellular carcinoma…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Erlotinib for Hepatocellular Carcinoma Chemoprevention [Phase 2]
Phase 2 clinical trial evaluating erlotinib for chemoprevention of hepatocellular carcinoma in patients with cirrhosis or advanced liver fib…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Evaluation of Risk of hEpatocellular Carcinoma [NA]
This clinical trial update describes an ongoing study evaluating the risk of hepatocellular carcinoma in patients with non-alcoholic steatoh…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment [Phase 2]
A Phase 2 clinical trial update evaluating the combination of dalpiciclib and camrelizumab in hepatocellular carcinoma patients who have pre…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating BB102 for hepatocellular carcinoma is planned but not yet recruiting, sponsored by Broadenbio Ltd.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Next Generation " Pre-clinical Model for Colorectal Cancer Metastases and Hepatocellular Carcinomas
This clinical trial update reports the completion of a pre-clinical model study focused on colorectal cancer metastases and hepatocellular c…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations [Phase 1]
This Phase 1 trial update evaluates TYRA-430 in hepatocellular carcinoma and FGFR-altered solid tumors, highlighting safety signals and prel…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients [NA]
This clinical trial evaluates liver-directed interventional radiology therapies and hypofractionated image-guided radiation therapy for hepa…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies [NA]
A clinical trial is evaluating high dose-rate brachytherapy for unresectable primary and metastatic liver malignancies. The study is current…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE
This clinical trial explores using deep learning-based multidimensional body composition mapping to predict outcomes for hepatocellular carc…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial [NA]
A randomized noninferiority trial comparing 15-minute versus 45-minute Pringle maneuver during liver cancer resection is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.
A clinical trial update collecting data on liver cancer patients treated with pembrolizumab, atezolizumab, or lenvatinib after 2019 and anal…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
This completed clinical trial investigates predictive factors for survival after surgical resection across the full spectrum of anatomically…
-
CLINICAL_TRIALS withdrawal · 2025-11-18Clinical Trial Update: A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma [Phase 2]
The trial PRISM evaluating preoperative irradiation with tremelimumab and ongoing durvalumab for resectable/advanced hepatocellular carcinom…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Interventional AI-Human Collaboration for Liver Tumor Diagnosis [NA]
Completed interventional clinical trial examining an AI–human collaboration approach for diagnosing liver tumors. The study encompasses hepa…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Atezolizumab and Bevacizumab Plus TACE-HAIC for Unresectable Advanced HCC: a Phase 2 Clinical Trial [Phase 2]
A Phase 2 clinical trial evaluating the combination of atezolizumab and bevacizumab with TACE-HAIC for unresectable advanced hepatocellular …
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) Versus Camrelizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation [Phase 2]
Phase 2 trial evaluating camrelizumab plus rivoceranib versus camrelizumab as adjuvant therapy for hepatocellular carcinoma at high risk of …
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions [Phase 2]
Phase 2 clinical trial testing an immunotherapy for hepatocellular carcinoma in patients with moderately altered liver function has complete…